Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 2 pseudogene 1 (SLC2AXP1)
- Target
- SLC2AXP1
- Molecular classification
- Other (pseudogene; not a functional transporter, enzyme, receptor, etc.)
01
Overview
SLC2AXP1 (solute carrier family 2 pseudogene 1) is classified as a pseudogene, meaning it is a nonfunctional DNA sequence resembling members of the solute carrier family 2 (facilitated glucose transporter) genes. It does not produce a functional protein, does not act as a transporter, receptor, enzyme, or any other known drug target, and currently has no established biological or clinical relevance[4][5]. Pseudogenes can arise through gene duplication or retrotransposition but typically lack coding capacity due to mutations or deletions. There are no known biological functions, disease associations, interacting compounds, or role in patient stratification for this locus. If you are seeking information on a functional member of the solute carrier family 2, such as SLC2A1 (GLUT1) or SLC2A2 (GLUT2), those are bona fide glucose transporters involved in biological processes and diseases[1][3]; SLC2AXP1 is not.
- Other names
- Solute carrier family 2 (facilitated glucose transporter), member 1 pseudogenesolute carrier family 2 (facilitated glucose transporter), pseudogene 1SLC2AXP1
Beyond the preview
Go deeper on Solute carrier family 2 pseudogene 1 (SLC2AXP1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Solute carrier family 2 pseudogene 1 (SLC2AXP1).